Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Adenocarcinoma”

6,465 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,465 results

Testing effectiveness (Phase 2)WithdrawnNCT00882765
What this trial is testing

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03013712
What this trial is testing

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

Who this might be right for
Colon CancerEsophageal CarcinomaPancreatic Cancer+3 more
First Affiliated Hospital of Chengdu Medical College 60
Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Large-scale testing (Phase 3)Study completedNCT00026338
What this trial is testing

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NCIC Clinical Trials Group 569
Not applicableLooking for participantsNCT05764551
What this trial is testing

The Application of Serum DNA Methylation for Patients With HCC

Who this might be right for
Hepatocellular Carcinoma
Chiayi Christian Hospital 100
Early research (Phase 1)Study completedNCT00056537
What this trial is testing

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer
Active Biotech AB 44
Testing effectiveness (Phase 2)Study completedNCT00022477
What this trial is testing

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 24
Not applicableLooking for participantsNCT06101277
What this trial is testing

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Who this might be right for
Esophageal CancerSmall Bowel CancerGastroesophageal-junction Cancer+8 more
University of California, Davis 300
Testing effectiveness (Phase 2)UnknownNCT00967655
What this trial is testing

Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer

Who this might be right for
Colorectal Cancer
Loma Linda Oncology Medical Group, Inc. 54
Not applicableUnknownNCT03221335
What this trial is testing

EUS-guided RFA for Solid Abdominal Neoplasms

Who this might be right for
Digestive System Neoplasms
Chinese University of Hong Kong 30
Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Not applicableUnknownNCT04434989
What this trial is testing

SBRT Versus Ablation for Perivascular Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 170
Not applicableUnknownNCT03619668
What this trial is testing

Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment

Who this might be right for
Rectal CancerRectal AdenocarcinomaLocally Advanced Malignant Neoplasm
Aalborg University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT03199274
What this trial is testing

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Thomas Jefferson University 104
Testing effectiveness (Phase 2)Study completedNCT00003760
What this trial is testing

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center at San Antonio 3
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT06519578
What this trial is testing

Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
RenJi Hospital 1,115
Not applicableLooking for participantsNCT05444478
What this trial is testing

Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaMicrowave AblationLiver Cancer+2 more
Sun Yat-sen University 274
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04017650
What this trial is testing

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Who this might be right for
BRAF NP_004324.2:p.V600EMetastatic Colon AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+13 more
M.D. Anderson Cancer Center 38
Load More Results